Discover
OBIO
Orchestra BioMed Holdings, Inc.
6.08
2 x 3.00
2 x 5.35
bid
ask
+
0.30
5.19%
2 @ 07:30 PM
6.05 -0.03 (0.49%)
| Ytd | 46.51% | |
| 1y | 142.23% |
5.71
day range
6.30
2.35
52 week range
6.12
| Open | 5.74 | Prev Close | 5.78 | Low | 5.71 | High | 6.30 | Mkt Cap | 365.44M |
| Vol | 1.14M | Avg Vol | 367.02K | EPS | -0.84 | P/E | N/A | Forward P/E | -2.66 |
| Beta | 0.41 | Short Ratio | 12.51 | Inst. Own | 54.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 4.64 | 200-d Avg | 4.32 | 1yr Est | 15.60 |
| Income Statement | |||
| Total Revenue | 88.00K | ||
| Revenues (USD) | 88.00K | ||
| Cost of Revenue | 25.00K | ||
| Gross Profit | 63.00K | ||
| Operating Expenses | 22.42M | ||
| Research and Development Expense | 16.59M | ||
| Selling, General and Administrative Expense | 5.83M | ||
| Operating Income | -22.36M | ||
| Interest Expense | 1.77M | ||
| Net Income | -23.75M | ||
| Net Income Common Stock | -24.08M | ||
| Net Income Common Stock (USD) | -24.08M | ||
| Consolidated Income | -23.75M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -21.99M | ||
| Earning Before Interest & Taxes (USD) | -21.99M | ||
| Preferred Dividends Income Statement Impact | 324.00K | ||
| Weighted Average Shares | 63.81M | ||
| Weighted Average Shares Diluted | 63.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.47M | ||
| Cash and Equivalents (USD) | 20.47M | ||
| Investments | 89.49M | ||
| Investments Current | 89.49M | ||
| Trade and Non-Trade Receivables | 51.00K | ||
| Current Assets | 111.24M | ||
| Property, Plant & Equipment Net | 3.22M | ||
| Total Assets | 115.70M | ||
| Debt Current | 808.00K | ||
| Total Debt | 70.76M | ||
| Current Liabilities | 13.47M | ||
| Debt Non-Current | 69.95M | ||
| Total Liabilities | 86.28M | ||
| Accumulated Retained Earnings (Deficit) | -407.02M | ||
| Accumulated Other Comprehensive Income | -81.00K | ||
| Shareholders Equity | 19.32M | ||
| Shareholders Equity (USD) | 19.32M | ||
| Assets Non-Current | 4.46M | ||
| Total Debt (USD) | 70.76M | ||
| Inventory | 250.00K | ||
| Liabilities Non-Current | 72.81M | ||
| Trade and Non-Trade Payables | 6.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 262.00K | ||
| Net Cash Flow from Financing | 34.75M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.89M | ||
| Capital Expenditure | -254.00K | ||
| Issuance (Purchase) of Equity Shares | 8.00K | ||
| Issuance (Repayment) of Debt Securities | 35.00M | ||
| Net Cash Flow from Investing | -23.31M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -23.05M | ||
| Net Cash Flow from Operations | -19.33M | ||
| Share Based Compensation | 2.51M | ||